Bioptron

What Bioptron does

Bioptron AG is a Swiss medical device company, headquartered in Wollerau, that designs, manufactures, and globally distributes the BIOPTRON Hyperlight Therapy System. The company is a wholly-owned subsidiary of Zepter Group, an international conglomerate that provides distribution infrastructure across 50+ countries. Founded in 1988, Bioptron has operated for over three decades in the medical light therapy segment with a small headcount of 11-50 employees.

The company's core technology is the patented BIOPTRON Hyperlight system, which uses C60 (Fullerene) molecule optics and a Brewster mirror polarization system to produce hyperpolarized, linearly polarized (95%), polychromatic (350-3400 nm), incoherent, low-energy light at a controlled intensity of 2.4 J/cm² per minute. The product line consists of three hardware SKUs—MedAll, Pro 1, and 2—differentiated primarily by filter diameter and intended use case, plus an Oxy Sterile Spray companion product. Devices are EU-certified under Directive 93/42/CEE as medical devices and are clinically tested for wound care, pain management, dermatology, pediatrics, SAD, sports medicine, aesthetic/anti-aging, and veterinary applications.

Bioptron's revenue model is a one-time hardware sale at RRP pricing, distributed through a hybrid go-to-market: an authorized distributor network in 50+ countries, direct-to-consumer e-commerce via country-specific websites, and a professional/medical channel that includes dedicated Doctor's Corner, veterinary, and BIMB resources. Customer segments are horizontal and include individual consumers seeking home wellness, healthcare professionals in dermatology, physiotherapy, aesthetic medicine, and sports medicine, as well as veterinary practitioners. No recurring subscription, SaaS, or consumables-driven revenue model is evident in the source material.

Name

Bioptron

Legal name

Bioptron AG

Website

https://bioptron.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

11–50 employees

Short description

Bioptron AG, a Swiss subsidiary of Zepter Group, manufactures and globally distributes the BIOPTRON Hyperlight Therapy System, a line of patented polarized light therapy medical devices sold through distributors in 50+ countries to healthcare professionals and individual consumers for wound care, pain, dermatology, and aesthetic applications.

Ownership category

akta.pro rank

Product category

Medical Light Therapy Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Irradiation Apparatus Manufacturing (334517)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Optical Instruments & Lenses (3827)

akta.pro primary industry

Infrared Therapy (Infrared Sauna & Light Therapy) (HSADAKAG)

akta.pro secondary industries

Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning) (CRABAKAI), Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices) (CRACAQAL), Optoelectronic Components (LEDs, photodiodes, optocouplers, optical sensors) (IMAGAJAF)

Keywords

• Light therapy devices
• Medical light therapy
• Polarized light therapy
• Hyperlight therapy system
• Photobiostimulation devices

Headquarters

HQ city

Wollerau

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Light Therapy Devices: Sale of BIOPTRON Hyperlight medical devices including BIOPTRON MedAll, Pro 1, and 2 models. Devices are one-time purchases with 5-year warranty. Prices are listed as RRP on bioptron.com with potential variations for ClubLive100 members.
2. Professional Medical Device Sales: Sale of devices to healthcare professionals, hospitals, and clinics for professional use. The company targets both professional medical market and consumer home use market.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

BIOPTRON AG manufactures and distributes medical light therapy devices based on its proprietary C60 Hyperlight Optics technology. The company sells the BIOPTRON Hyperlight Therapy System, which includes three device models (MedAll, Pro 1, and 2) that emit 95% linearly polarized, polychromatic (350-3400nm), incoherent, low-energy light for medical, aesthetic, and wellness applications including wound healing, pain management, dermatology, anti-aging, sports medicine, and pediatric conditions. Products are sold through a global network of authorized distributors in 50+ countries and directly to consumers through country-specific websites.

Product overview

Bioptron AG (part of Zepter Group) offers the BIOPTRON Hyperlight Therapy System, a family of three medical light therapy devices (BIOPTRON MedAll, Pro 1, and 2) that deliver polarized polychromatic incoherent light therapy. The devices share identical light characteristics but vary in size and filter diameter (5cm to 15cm) to suit different treatment needs from personal home use to professional clinical settings. The technology is Swiss-made, clinically tested, medically certified per EU Directive 93/42/CEE, and inspired by Nobel Prize-winning discoveries related to C60 particles and light therapy. The product line also includes the Oxy Sterile Spray as a companion product.

Differentiator

Problem solved

Functional benefit

Brands

• BIOPTRON MedAll: Compact medical device with enlarged filter diameter and 65% increased light surface area for flexible use in professional and domestic environments.
• BIOPTRON Pro 1
• BIOPTRON 2
• Oxy Sterile Spray

Products and services

• BIOPTRON MedAll The latest certified and clinically tested medical device in the BIOPTRON Hyperlight range, designed for flexible and comfortable use in professional and domestic environments. Features an enlarged medical filter diameter with 65% increased light surface area for more effective medical treatment.
• BIOPTRON Pro 1 Professional medical light therapy device with approximately 11 cm filter diameter allowing treatment of small and large areas. Features adjustable height and head inclination with 360° rotation capability, control panel, display, and integrated distance rod for convenient usage in nearly any position.
• BIOPTRON 2 Medical light therapy device with 15 cm filter diameter for treating larger body areas. Part of the BIOPTRON Hyperlight Therapy System product line, sharing identical light characteristics with other devices in the range.
• Oxy Sterile Spray Companion sterile spray product designed for use alongside BIOPTRON Hyperlight therapy treatments. Sold separately to support the primary light therapy devices.

Quantifiable outcome

• Clinically proven to increase collagen, elastin and water content in dermis layers after 4 weeks of treatment (joint study with University of Belgrade)
• +3 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered core.

• Zepter Medical Team of SerbiacoreStrategic or Co-development PartnerCollaborative research partnership for clinical studies. Conducted joint study with University of Belgrade's Biomedical Engineering Department demonstrating BIOPTRON's effect on collagen, elastin and water content in skin using Optomagnetic Imaging Spectroscopy (OMIS).
• University of Belgrade - Biomedical Engineering DepartmentcoreStrategic or Co-development PartnerAcademic research partnership for clinical validation of BIOPTRON Hyperlight technology. Joint study demonstrated incredible increase of collagen, elastin and water in different layers of the dermis after 4 weeks of treatment.
• Zepter GroupcoreOthersBIOPTRON AG is a subsidiary of Zepter Group, an international company specializing in high-quality consumer and medical products. Zepter provides global distribution infrastructure and brand support.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Mito Red Light: Mito Red Light sells red/NIR light therapy panels to consumers and clinicians, competing in the same wellness and recovery use cases that Bioptron addresses with its professional and home devices.
• Therabody: Therabody builds consumer and professional recovery and wellness devices (e.g., percussive therapy, light therapy). Competes with Bioptron's sports-medicine and home-use wellness positioning, but with a more digitally native, D2C-led brand.
• Joovv: Joovv is a digitally native red-light therapy panel brand that has built a strong direct-to-consumer footprint in recovery, wellness, and skin health. Comparable to Bioptron's consumer home-use positioning but with a more modern e-commerce and subscription-oriented GTM.
• NuFACE: NuFACE sells microcurrent facial toning devices to professionals and consumers, competing in the same at-home anti-aging beauty-device category where Bioptron positions its Hyperlight devices.
• PlatinumLED Therapy Lights: PlatinumLED offers high-power red and near-infrared light therapy panels for home users, athletes, and clinicians — overlapping with Bioptron's sports medicine, pain, and home-use segments at a lower price point.

Direct peers

• LightStim: LightStim makes FDA-cleared LED light therapy devices sold both to spas/medical professionals and directly to consumers for wrinkles, pain, and acne — a near-direct horizontal peer to Bioptron's Hyperlight device family.
• Omnilux (GlobalMed Technologies): Omnilux is a clinical LED light therapy brand used by dermatologists and aesthetics practices for acne, skin rejuvenation, and pain — overlapping with Bioptron's dermatology, anti-aging, and wound-care claims, and distributed through professional and home-use channels.
• Celluma Light Therapy: Celluma manufactures FDA-cleared LED light therapy devices for dermatology, pain management, and aesthetic professionals, plus a consumer line. Directly comparable to Bioptron's light-therapy medical device offering across the same clinical and home-use segments.

Others

• CurrentBody: CurrentBody is a specialist online retailer of clinical-grade beauty devices, including LED masks and light therapy products. Acts as both a potential channel for Bioptron's home-use devices and a competing go-to-market for end customers seeking light-therapy solutions.

Broad incumbents

• Solta Medical (Bausch + Lomb): Solta Medical, owned by Bausch + Lomb, markets energy-based aesthetic devices (Clear + Brilliant, Thermage) used by dermatologists and plastic surgeons. A broad incumbent in medical/clinical light and energy-based aesthetic devices, partially overlapping with Bioptron's clinical aesthetic use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCHAd7m5V43iAymL9Ghtzt9w
• Facebookfacebook.com/bioptron

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioptron